The BNN 2017 meeting program was full of scientific and clinical lectures as well as audit on practical topic such as patient consent.
On Thursday 21st September, we all met at Grove auditorium of Magdalen college to listen to Professeur Bernard Poulain, who explains through examples how basic science can guide the injectors in clinical practice. He reviewed basic topics such as the composition of the botulinum toxin complex, the quick dissociation of the complex which liberates the neurotoxin, the different commercial preparations of BoNT-A, the action of the neurotoxin on the exocytosis. It was also fascinating to hear about the distribution of the toxin after the injection and the factors controlling the duration of action in therapeutic.
My talk on cervical dystonia as a therapeutic emergency was based on the natural history of the CD, the outcome datas from treating musician’s cramp and from surgical DBS on generalised dystonia. in addition the socio economic study shows that eating patients with CD with BoNT-A injections helps to keep p[atients in employment.
On Friday 22nd September, the talks were focusing on the New frontiers in Botulinum toxin indications such as the neurogenic bladder with Mr Dudley Robinson, the neuropathic pain with dr Daniel Ranoux and the tics with dr Peter Moore. The use of BoNT-A as pain killer will extent the indication of the BoNT-A to the painful neuropathy, the trigeminal neuralgia and the post zoster neuralgia.
Dr Michael Lewis presented new research datas on the psychological impact of BoNT-A by acting on the muscle responsible of the expression of emotions with the facial feedback theory which could support the possible role of BoNT-A in the treatment of depression.
Dr Christopher Kobylecki presented a on going research in Manchester, trying to develop algorithms to recognise pattern of ultrasound pictures of the cervical muscles in normal and dystonic individuals.
The neurotoxin club in the afternoon , led by dr Tim Harrower and Sunil Wilmalartna was the time for sharing complex cases ; dr Sajida Javaid presented her “Easy read” information booklet to help patients with cognitive impairment to better understand botulinum toxin treatment and set expectations for clinic appointment.
Thee BNN matters session, chair by Dr Miles Humberstone, was mainly on the procedure of consenting patients before BONT-A injections , based on a audit among BNN members, which triggered very animated discussion of the participants.
The all meeting went very smoothly, thanks to our organisers Jane and Graham Lamond from Mondale Events
The friendly atmosphere is the hallamark of this annual meeting!
Dr Marie-Helene Marion, chair of the BNN